Literature DB >> 2991884

Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.

M P Kamps, J E Buss, B M Sefton.   

Abstract

p60src, the transforming protein kinase of Rous sarcoma virus, contains the 14-carbon saturated fatty acid, myristic acid, linked through an amide bond to the alpha-amino group of its NH2-terminal glycine residue. Myristic acid is known to be attached to four other eukaryotic proteins. In each case the fatty acid is also linked through an amide bond to an NH2-terminal glycine. We have used oligonucleotide-directed mutagenesis to examine the amino acid specificity of the enzyme that myristoylates the NH2 terminus of these proteins. Replacement of the NH2-terminal glycine in p60src with either alanine or glutamic acid prevented myristoylation completely. This indicates that the myristoylating enzyme may have an absolute specificity for glycine. Strikingly, neither nonmyristoylated mutant src protein induced morphological transformation of infected cells, even though wild-type levels of phosphorylation of cellular proteins on tyrosine were observed in these cells. Since conversion of the NH2-terminal residue from glycine to alanine should have little effect on the conformation of p60src, the inability of this mutant p60src protein to induce morphological transformation suggests that the myristoyl moiety is essential for the transforming activity of the protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991884      PMCID: PMC390438          DOI: 10.1073/pnas.82.14.4625

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The NH2-terminal sequence of the avian oncovirus gag precursor polyprotein (Pr76gag).

Authors:  R D Palmiter; J Gagnon; V M Vogt; S Ripley; R N Eisenman
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

2.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

3.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

4.  Evidence that the src gene product of Rous sarcoma virus is membrane associated.

Authors:  J G Krueger; E Wang; A R Goldberg
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

5.  Structural analysis of the avian sarcoma virus transforming protein: sites of phosphorylation.

Authors:  M S Collett; E Erikson; R L Erikson
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

6.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

7.  Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog.

Authors:  J E Buss; B M Sefton
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

8.  Localization of the ASV src gene product to the plasma membrane of transformed cells by electron microscopic immunocytochemistry.

Authors:  M C Willingham; G Jay; I Pastan
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

9.  Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes.

Authors:  H Ushiro; S Cohen
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

10.  Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein.

Authors:  A M Schultz; L E Henderson; S Oroszlan; E A Garber; H Hanafusa
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

View more
  157 in total

Review 1.  Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Authors:  H LeVine
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

2.  The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.

Authors:  M Shanzer; I Ricardo-Lax; R Keshet; N Reuven; Y Shaul
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

3.  Multiple cDNAs encoding the esk kinase predict transmembrane and intracellular enzyme isoforms.

Authors:  E M Douville; D E Afar; B W Howell; K Letwin; L Tannock; Y Ben-David; T Pawson; J C Bell
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

4.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

5.  A myristylated form of the sea oncoprotein can transform chicken embryo fibroblasts.

Authors:  A J Crowe; M J Hayman
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Myristoylation of an inhibitory GTP-binding protein alpha subunit is essential for its membrane attachment.

Authors:  T L Jones; W F Simonds; J J Merendino; M R Brann; A M Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 7.  Acylation of viral and eukaryotic proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

8.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  Capsid protein VP4 of poliovirus is N-myristoylated.

Authors:  A V Paul; A Schultz; S E Pincus; S Oroszlan; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

10.  The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to beta-adrenergic agonists in cells overexpressing c-src.

Authors:  J S Moyers; A H Bouton; S J Parsons
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.